Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationTransplantation ConditioningGraft vs Host DiseaseTransplantation, AutologousPeripheral Blood Stem Cell TransplantationMyeloablative AgonistsStem CellsHematologic NeoplasmsTransplantation ChimeraBone Marrow TransplantationTreatment OutcomeBusulfanTissue DonorsGraft vs Leukemia EffectRemission InductionRecurrenceVidarabineCord Blood Stem Cell TransplantationGraft SurvivalHistocompatibility TestingHematopoietic Stem CellsLiver TransplantationWhole-Body IrradiationGraft vs Tumor EffectCombined Modality TherapyMultiple MyelomaImmunosuppressive AgentsRetrospective StudiesLeukemiaLeukemia, Myeloid, AcuteMelphalanMesenchymal Stem Cell TransplantationLymphocyte TransfusionDisease-Free SurvivalSiblingsHistocompatibilitySurvival AnalysisSalvage TherapySurvival RateMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCell TransplantationCytomegalovirus InfectionsAntilymphocyte SerumKidney TransplantationHematopoietic Stem Cell MobilizationLymphocyte DepletionHepatic Veno-Occlusive DiseaseEmbryonic Stem CellsCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsChimerismPrecursor Cell Lymphoblastic Leukemia-LymphomaMinor Histocompatibility AntigensTime FactorsNeoplasm, ResidualAdult Stem CellsVirus ActivationAntigens, CD34HLA AntigensHematologic DiseasesFollow-Up StudiesAcute DiseaseTransplantation ImmunologyT-LymphocytesPrognosisAnemia, AplasticCytomegalovirusLymphoma, Non-HodgkinHeart TransplantationGraft RejectionCytarabinePluripotent Stem CellsCell DifferentiationGranulocyte Colony-Stimulating FactorImmunosuppressionHodgkin DiseaseTransplantation, IsogeneicLung TransplantationAntineoplastic AgentsLeukemia, MyeloidStem Cell NichePrimary MyelofibrosisNeural Stem CellsInfectionMesenchymal Stromal CellsAntibodies, NeoplasmImmunocompromised HostEtoposideLymphoproliferative DisordersCyclosporineUnrelated DonorsLiving DonorsBone Marrow CellsRoseolovirus InfectionsLeukemia, Myeloid, Accelerated PhaseOrgan TransplantationInduced Pluripotent Stem Cells